| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman, President & CEO
3 companies
Robert J Dennis last filed a Form 4 in April 2025, as Director at GCO. The filings on record cover 3 companies. Robert J Dennis's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 26,601 shares of HCA.
Robert J Dennis has 41 Form 4 filings on record from February 2015 to April 2025, across 3 companies: Director at HCA Healthcare (HCA), 2018–2025; Director at CoreCivic (CXW), 2015–2025; Director at Genesco (GCO), 2015–2020.
The 47 reported transactions were 24 stock awards, 12 open-market sales, 7 tax withholdings and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $595K and 9 sales worth about $7.2M.
The only open-market purchase was 25,000 shares of GCO at an average $23.81 on September 6, 2017, about $595K.
The largest open-market sale was 16,685 shares of GCO at an average $65.09 on June 9, 2016, about $1.1M.
Shares as reported in the last Form 4 for each company; the most recent is from April 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | CXW Corecivic, Inc. | Director | Sell | 20,000 | $22.00 | $440,088.00 | -20.8% | -16.2% | -22.2% | |
| Jun 12, 2020 | GCO Genesco Inc | Director | Sell | 25,000 | $21.16 | $529,042.50 | -8.7% | - | - | |
| Jan 24, 2019 | GCO Genesco Inc | Chairman, President & CEO | Sell | 22,760 | $47.21 | $1,074,594.05 | -8.3% | - | - | |
| Sep 6, 2017 | GCO Genesco Inc | Chairman, President & CEO | Buy | 25,000 | $23.81 | $595,150.00 | +12.2% | - | - | |
| Dec 6, 2016 | GCO Genesco Inc | Chairman, President & CEO | Sell | 15,000 | $68.42 | $1,026,276.00 | -8.5% | - | - | |
| Jun 9, 2016 | GCO Genesco Inc | Chairman, President & CEO | Sale+OE | 16,685 | $65.09 | $1,086,041.27 | -9.9% | - | - | |
| Mar 15, 2016 | GCO Genesco Inc | Chairman, President & CEO | Sell | 15,000 | $65.90 | $988,446.00 | -8.6% | - | - | |
| Dec 9, 2015 | GCO Genesco Inc | Chairman, President & CEO | Sell | 15,000 | $55.80 | $836,941.50 | -7.9% | - | - | |
| Jun 8, 2015 | GCO Genesco Inc | Chairman, President & CEO | Sell | 10,000 | $67.16 | $671,635.00 | -5.6% | - | - | |
| Mar 27, 2015 | GCO Genesco Inc | Chairman, President & CEO | Sale+OE | 8,189 | $69.26 | $567,164.08 | -4.4% | - | - |